Source-grounded facts extracted from NOVANTA INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
NOVANTA INC issued 2,142,857 common shares of common stock to institutional and other accredited investors for $140.00 per share.
“The Purchasers agreed to purchase an aggregate of 2,142,857 common shares, no par value, of the Company (the “Common Shares”), at a purchase price per share of $140.00, for an aggregate purchase price of approximately $300.0 million.”
NOVANTA INC entered into Registration Rights Agreement with certain institutional and other accredited investors (effective 2026-06-08).
“Also on June 8, 2026, the Company entered into a Registration Rights Agreement (the "Registration Rights Agreement") with the Purchasers”
NOVANTA INC entered into Purchase Agreement with certain institutional and other accredited investors valued at approximately $300.0 million (effective 2026-06-08).
“On June 8, 2026, the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") for a private placement (the "Private Placement") with certain institutional and other accredited investors”
NOVANTA INC amended Third Amendment to Fourth Amended and Restated Credit Agreement with Bank of America, N.A., as administrative agent and lender, and the other lenders party thereto.
“In connection with the Transaction, Intermediate Parent, the Company, and certain wholly-owned subsidiaries of the Company entered into the Third Amendment to Fourth Amended and Restated Credit Agreement (the “ Third Amendment ”), with Bank of America, N.A., as administrative agent and lender, and the other lenders party thereto, which amends that certain Fourth Amended and Restated Credit Agreement dated as of June 27, 2025 (as amended, the “ Credit Agreement”).”
NOVANTA INC entered into Equity Purchase Agreement with Runway Midco, LLC valued at $1,200,000,000 in cash (effective 2026-06-08).
“On June 8, 2026, Novanta Inc., a Canadian corporation (the “ Company ”), Novanta Medical Technologies Corp., a Delaware corporation and an indirect subsidiary of the Company (“ Buyer ”), Novanta Corporation, a Michigan corporation (“ Intermediate Parent ”, and together with the Company and the Buyer, the “ Buyer Parties ”), Runway Midco, LLC, a Delaware limited liability company (“ Seller ”), and Runway Buyer, LLC, a Delaware limited liability company and direct wholly owned subsidiary of Seller (“ Runway Buyer ”), entered into an Equity Purchase Agreement (the “ Purchase Agreement ”), pursuant to which Buyer will acquire from Seller all of the issued and outstanding limited liability company interests (the “ Purchased Interests ”) of Runway Buyer (the “ Transaction ”). Transaction Consideration Subject to the terms and conditions of the Purchase Agreement, at the closing of the Transaction (the “ Closing ”), the Buyer Parties will pay Seller $1,200,000,000 in cash (the “ Closing Consi”
NOVANTA INC shareholders approved Appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm to serve until the Company's next Annual Meeting of Shareholders in 2027 at the 2026-05-28 meeting.
“Item 3 — Appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm to serve until the Company's next Annual Meeting of Shareholders in 2027. Votes FOR Votes AGAINST Votes ABSTAINED 33,352,532 5,006 14,239”
NOVANTA INC shareholders approved Approval, on an advisory basis, of the Company's executive compensation at the 2026-05-28 meeting.
“Item 2 — Approval, on an advisory basis, of the Company’s executive compensation. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 31,065,978 695,736 13,010 1,597,053”
NOVANTA INC shareholders approved Election of nine directors for a term of office expiring on the date of the Company's next Annual Meeting of Shareholders in 2027 at the 2026-05-28 meeting.
“Item 1 — Election of directors for a term of office expiring on the date of the Company's next Annual Meeting of Shareholders in 2027, until their successor is elected or appointed, or until their earlier death, resignation, or removal. NOMINEE Votes FOR Votes WITHHELD Broker Non-Votes Lonny J. Carpenter 31,049,533 725,191 1,597,053 Matthew T. Farrell 31,739,890 34,834 1,597,053 Matthijs Glastra 30,975,206 799,518 1,597,053 R. Matthew Johnson 31,237,177 537,547 1,597,053 Mary Katherine Ladone 31,064,627 710,097 1,597,053 Maxine L. Mauricio 31,079,323 695,401 1,597,053 Thomas N. Secor 31,321,519 453,205 1,597,053 Darlene J. S. Solomon, Ph.D. 31,199,580 575,144 1,597,053 Frank A. Wilson 31,721,169 53,555 1,597,053”
NOVANTA INC amended Second Amendment to Fourth Amended and Restated Credit Agreement with Bank of America, N.A., as Administrative Agent and lender, and the other lenders party thereto valued at $200.0 million (effective 2026-05-15).
“On May 15, 2026 (the “Second Amendment Effective Date”), Novanta Inc. (the “Company”), Novanta Corporation (the “Lead Borrower”), Novanta UK Investments Holding Limited (the “U.K. Borrower”), Novanta Europe GmbH (the “German Borrower” and, together with the Company, the Lead Borrower and the U.K. Borrower, the “Borrowers”) and certain wholly-owned subsidiaries of the Company (the “Guarantors”) entered into the Second Amendment to Fourth Amended and Restated Credit Agreement (the “Second Amendment”), with Bank of America, N.A., as Administrative Agent and lender, and the other lenders party thereto”
NOVANTA INC incurred term loan of $200.0 million of delayed draw term loan commitments with Bank of America, N.A. at Base Rate plus a margin ranging from 0.00% to 0.75% per annum or SOFR, SONIA or maturing June 27, 2030.
“On May 15, 2026 (the “Second Amendment Effective Date”), Novanta Inc. (the “Company”), Novanta Corporation (the “Lead Borrower”), Novanta UK Investments Holding Limited (the “U.K. Borrower”), Novanta Europe GmbH (the “German Borrower” and, together with the Company, the Lead Borrower and the U.K. Borrower, the “Borrowers”) and certain wholly-owned subsidiaries of the Company (the “Guarantors”) entered into the Second Amendment to Fourth Amended and Restated Credit Agreement (the “Second Amendment”), with Bank of America, N.A., as Administrative Agent and lender, and the other lenders party thereto, which amends that certain Fourth Amended and Restated Credit Agreement dated as of June 27, 2025 (as amended, the “Credit Agreement”). The Second Amendment, among other things, amends the Credit Agreement to establish $200.0 million of delayed draw term loan commitments (the “2026 Delayed Draw Term Loan Commitments”, and the U.S. dollar term loans funded thereunder, the “Delayed Draw Term Lo”
NOVANTA INC reported the fiscal quarter ended April 3, 2026 results: revenue $258 million, net income $21 million, EPS $0.51.
“First Quarter 2026 GAAP Revenue increased 10% to $258 million • First Quarter 2026 GAAP Net Income was $21 million, and Adjusted EBITDA increased 14% to $57 million • First Quarter 2026 GAAP Diluted EPS was $0.51”
NOVANTA INC amended credit facility of approximately $1.0 billion with Bank of America, N.A. at Base Rate plus a margin ranging between zero and 0.75% per annum, or SOFR, SONIA maturing June 2030.
“were $392.4 million as of March 28, 2025, the end of the Company’s first fiscal quarter of 2025. The Agreement provides for an aggregate credit facility of approximately $1.0 billion, comprised of a €65.31 million euro-denominated 5-year term loan facility (the “Euro Term Loans”), a $75.0 million U.S. dollar denominated 5-year term loan facility (the “U.S.”
NOVANTA INC announced a restructuring with charges of approximately $20 million to $25 million.
“strategies in areas anticipated to have a minimal long-term impact on the Company's overall business performance. The Company estimates that it will incur approximately $20 million to $25 million in pre-tax charges in connection with the 2025 Restructuring Plan, consisting of employee-related costs, third-party manufacturing moving costs, contract”
Peter Chang departed as Chief Accounting Officer at NOVANTA INC.
“Mr. Burke succeeds Peter Chang, Chief Accounting Officer and Corporate Controller of the Company, who departed from the role effective August 22, 2024.”
John Burke was appointed as Chief Accounting Officer at NOVANTA INC.
“On August 22, 2024, John Burke, formerly Vice President of Global Accounting for Novanta Inc. (the “Company”), was appointed Chief Accounting Officer of Novanta Inc. and assumed the role of principal accounting officer.”
Brian Young departed as Chief Human Resources Officer at NOVANTA INC.
“On August 1, 2024, Novanta Inc. (the “Company”) announced that Brian Young, Chief Human Resources Officer (“CHRO”) of the Company, would no longer serve as the CHRO, effective on November 1, 2024, or such earlier date as may be agreed between Mr. Young and determined by the Company.”
Mary Kay Ladone was elected as Director at NOVANTA INC.
“On July 11, 2024, the Board elected Mary Katherine (Mary Kay) Ladone to the Board to fill the vacancy created by Ms. Owen’s resignation, effective July 11, 2024.”
Katherine A. Owen resigned as Director at NOVANTA INC.
“On July 11, 2024, Katherine A. Owen resigned as a member of the Board of Directors (the “Board”) of Novanta Inc. (the “Company”) and the Audit Committee of the Board, effective immediately.”
NOVANTA INC shareholders approved Appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm at the 2024-05-08 meeting.
“Item 3 — Appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm to serve until the Company's next Annual Meeting of Shareholders in 2025. Votes FOR Votes WITHHELD 33,816,295 39,886”
NOVANTA INC shareholders approved Approval, on an advisory basis, of the Company's executive compensation at the 2024-05-08 meeting.
“Item 2 — Approval, on an advisory basis, of the Company's executive compensation. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 32,388,395 625,061 13,435 829,290”
NOVANTA INC shareholders approved Election of directors for a term of office expiring on the date of the Company's next Annual Meeting of Shareholders in 2025 at the 2024-05-08 meeting.
“Item 1 — Election of directors for a term of office expiring on the date of the Company's next Annual Meeting of Shareholders in 2025, until their successor is elected or appointed, or until their earlier death, resignation, or removal.”
NOVANTA INC reported first quarter 2024 results: revenue $231 million, net income $15 million, EPS $0.41.
“EX-99.1 (EX-99.1) --- EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE May 7, 2024 Novanta Announces Financial Results for the First Quarter 2024 • First Quarter 2024 GAAP Revenue of $231 million • First Quarter 2024 GAAP Net Income of $15 million • First Quarter 2024 GAAP Diluted Earnings Per Share of $0.41 • First Quarter 2024 Adjusted Earnings Per Share of $0.74 •”
NOVANTA INC engaged Deloitte & Touche LLP as its auditor.
“Effective as of March 14, 2024, the Board approved the engagement of Deloitte & Touche LLP (“Deloitte”) as the Company’s independent registered public accounting firm.”
NOVANTA INC reported financial results for the fiscal quarter and full year ended December 31, 2023.
“On February 28, 2024, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter and full year ended December 31, 2023. A copy of this press release is attached hereto as Exhibit 99.1.”
NOVANTA INC incurred revolving credit of $198.0 million with Bank of America, N.A. maturing in December 2027.
“On January 2, 2024, Novanta Inc. (the “Company”) drew down $198.0 million on its revolving credit facility under its Third Amended and Restated Credit Agreement, as amended, by and among the Company, certain of the Company’s subsidiaries, Bank of America, N.A., as Administrative Agent, Swing Line Lender, L/C Issuer and lender, and the other lender parties thereto (“Third Amended and Restated Credit Agreement”).”
NOVANTA INC entered into Securities Purchase Agreement with Motion Solutions Holdings LLC and Motion Solutions Parent Corp. valued at $189.0 million (effective 2023-11-14).
“On November 14, 2023, Novanta Corporation (the “Buyer”), a wholly-owned subsidiary of Novanta Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Motion Solutions Holdings LLC (the “Seller”) and Motion Solutions Parent Corp. (“Motion Solutions”).”
NOVANTA INC reported third quarter 2023 results: revenue $221.5 million, net income $21.2 million, EPS $0.59.
“Third Quarter 2023 GAAP Revenue of $222 million • Third Quarter 2023 GAAP Net Income of $21 million • Third Quarter 2023 GAAP Diluted Earnings Per Share of $0.59”
NOVANTA INC reported the fiscal quarter ended June 30, 2023 results: revenue $229.5 million, net income $20.9 million, EPS $0.58 per diluted share.
“--- EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE August 8, 2023 Novanta Announces Financial Results for the Second Quarter 2023 • Second Quarter 2023 GAAP Revenue increased 7% to $229 million • Second Quarter 2023 GAAP Net Income of $21 million • Second Quarter 2023 GAAP Diluted Earnings Per Share of $0.58 • Second Quarter 2023 Adjusted Earnings Per Share of $0.80 •”
NOVANTA INC shareholders approved Appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm to serve until the 2024 annual meeting of shareholders. at the 2023-05-10 meeting.
“Item 3 — Appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm to serve until the 2024 annual meeting of shareholders. Votes FOR Votes WITHHELD 33,292,275 163,929”
NOVANTA INC shareholders approved Approval, on an advisory basis, of the Company’s executive compensation. at the 2023-05-10 meeting.
“Item 2 — Approval, on an advisory basis, of the Company’s executive compensation. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 31,773,157 931,107 16,777 735,163”
NOVANTA INC shareholders approved Election of directors for a term of office expiring on the date of the annual meeting of shareholders in 2024, until their successor is elected or appointed, or until their earlier death, resignation, or removal. at the 2023-05-10 meeting.
“Item 1 — Election of directors for a term of office expiring on the date of the annual meeting of shareholders in 2024, until their successor is elected or appointed, or until their earlier death, resignation, or removal. NOMINEE Votes FOR Votes WITHHELD Broker Non-Votes Lonny J. Carpenter 31,837,396 883,645 735,163 Matthijs Glastra 31,797,974 923,067 735,163 Barbara B. Hulit 32,507,292 213,749 735,163 Maxine L. Mauricio 31,868,149 852,892 735,163 Katherine A. Owen 32,674,886 46,155 735,163 Thomas N. Secor 31,783,438 937,603 735,163 Darlene J. S. Solomon, Ph.D. 31,739,831 981,210 735,163 Frank A. Wilson 32,502,373 218,668 735,163”
NOVANTA INC reported first quarter 2023 results: revenue $219.1 million, net income $18.3 million, EPS $0.51 diluted earnings per share or $0.74 adjusted diluted earnings per share.
“--- EX-99 Exhibit 99.1 FOR IMMEDIATE RELEASE May 9, 2023 Novanta Announces Financial Results for the First Quarter 2023 • First Quarter 2023 GAAP Revenue increased 7% to $219 million • First Quarter 2023 GAAP Net Income of $18 million • First Quarter 2023 GAAP Diluted Earnings Per Share of $0.51 • First Quarter 2023 Adjusted Earnings Per Share of $0.74 •”
NOVANTA INC reported financial results for the quarter and full year ended December 31, 2022.
“On March 1, 2023, Novanta Inc. (the “Company”) issued a press release announcing its financial results for the quarter and full year ended December 31, 2022.”
NOVANTA INC reported financial results for the third quarter 2022.
“On November 8, 2022, Novanta Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter ended September 30, 2022.”
Barbara B. Hulit was elected as Director at NOVANTA INC.
“On July 26, 2022, the Board of Directors (the “Board”) of the Company elected Barbara B. Hulit to the Board to fill an existing vacancy, effective July 26, 2022.”
Ira J. Lamel resigned as Director at NOVANTA INC.
“On July 26, 2022, Ira J. Lamel resigned as a director of Novanta Inc. (the “Company”), effective immediately.”
Darlene J. S. Solomon, Ph.D. was elected as director at NOVANTA INC.
“On June 28, 2022, the Board of Directors (the “Board”) of the Company elected Darlene J. S. Solomon, Ph.D., to the Board to fill an existing vacancy, effective June 28, 2022.”
Brian King resigned as director at NOVANTA INC.
“On June 28, 2022, Brian King resigned as a director of Novanta Inc. (the “Company”), effective immediately.”
Deborah DiSanzo resigned as Director at NOVANTA INC.
“On November 6, 2021, Deborah DiSanzo, a member of the Board of Directors (the “Board”) of Novanta Inc. (the “Company”), informed the Company of her decision to resign from the Board, effective February 28, 2022, in order to focus her attention on her responsibilities as the President of Best Buy Health and other professional responsibilities.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.